These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1781 related articles for article (PubMed ID: 18171610)

  • 41. beta 2 Glycoprotein I--a key player in the antiphospholipid syndrome.
    Lutters BC; de Groot PG; Derksen RH
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):958-62. PubMed ID: 12455190
    [No Abstract]   [Full Text] [Related]  

  • 42. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus].
    Borodin AG; Baranov NG; Nasonov EL
    Klin Med (Mosk); 2001; 79(2):49-51. PubMed ID: 11419087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lupus anticoagulant in cardiovascular diseases: the role of beta2-glycoprotein I.
    de Groot PG; Bouma B; Lutters BC; Derksen RH
    Ann Med; 2000 Dec; 32 Suppl 1():32-6. PubMed ID: 11209979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship of lupus anticoagulant, anticardiolipin, anti-beta2-GPI and anti-prothrombin autoantibodies with history of thrombosis in patients with the clinical suspicion of APA-syndrome.
    D'Angelo A; Safa O; Crippa L; Garlando A; Sabbadini MG; Vigano' D'Angelo S
    Thromb Haemost; 1997 Aug; 78(2):967-8. PubMed ID: 9268210
    [No Abstract]   [Full Text] [Related]  

  • 46. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis of antiphospholipid syndrome.
    Bertolaccini ML; Khamashta MA; Hughes GR
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):40-6. PubMed ID: 16932626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgA anticardiolipin antibodies--relation with other antiphospholipid antibodies and clinical significance.
    Selva-O'Callaghan A; Ordi-Ros J; Monegal-Ferran F; Martinez N; Cortes-Hernandez F; Vilardell-Tarres M
    Thromb Haemost; 1998 Feb; 79(2):282-5. PubMed ID: 9493576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correct laboratory approach to APS diagnosis and monitoring.
    Pengo V; Banzato A; Denas G; Jose SP; Bison E; Hoxha A; Ruffatti A
    Autoimmun Rev; 2013 Jun; 12(8):832-4. PubMed ID: 23219767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.
    Sanfelippo MJ; Joshi A; Schwartz S; Meister JA; Goldberg JW
    Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of anti-beta 2-glycoprotein I antibodies.
    Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():15-7. PubMed ID: 8952753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antiphospholipid syndrome].
    Atsumi T; Koike T
    Nihon Rinsho; 1998 Jan; 56(1):215-23. PubMed ID: 9465693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
    Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laboratory tests for the antiphospholipid syndrome.
    Pericleous C; Ripoll VM; Giles I; Ioannou Y
    Methods Mol Biol; 2014; 1134():221-35. PubMed ID: 24497366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort.
    Petri M
    Lupus; 2010 Apr; 19(4):419-23. PubMed ID: 20353980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The geoepidemiology of the antiphospholipid antibody syndrome.
    Biggioggero M; Meroni PL
    Autoimmun Rev; 2010 Mar; 9(5):A299-304. PubMed ID: 19932199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Laboratory evaluation of the antiphospholipid syndrome.
    Abo SM; DeBari VA
    Ann Clin Lab Sci; 2007; 37(1):3-14. PubMed ID: 17311864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiphospholipid antibody syndrome and fetal outcome.
    Djelmis J; Radoncić E; Ivanisević M
    Acta Med Croatica; 2001; 55(3):123-30. PubMed ID: 11852731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 90.